These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16258457)

  • 1. Participation in cancer trials: recruitment of underserved populations.
    Paskett ED; Katz ML; DeGraffinreid CR; Tatum CM
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):607-13. PubMed ID: 16258457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.
    Bruner DW; Jones M; Buchanan D; Russo J
    J Clin Oncol; 2006 May; 24(14):2209-15. PubMed ID: 16682741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
    Joseph G; Dohan D
    Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closing the divide: diverse populations and cancer survivorship.
    Guidry JJ; Torrence W; Herbelin S
    Cancer; 2005 Dec; 104(11 Suppl):2577-83. PubMed ID: 16258930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that affect breast cancer treatment: underserved and minority populations.
    Hurd TC; James T; Foster JM
    Surg Oncol Clin N Am; 2005 Jan; 14(1):119-30, vii. PubMed ID: 15542003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to participation of minorities in clinical trials.
    Schmotzer GL
    Ethn Dis; 2012; 22(2):226-30. PubMed ID: 22764647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
    Steinberg ML; Fremont A; Khan DC; Huang D; Knapp H; Karaman D; Forge N; Andre K; Chaiken LM; Streeter OE
    Cancer; 2006 Dec; 107(11):2669-77. PubMed ID: 17078056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research.
    Seifer SD; Michaels M; Collins S
    Prog Community Health Partnersh; 2010; 4(1):37-46. PubMed ID: 20364077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
    Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying justice in clinical trials for diverse populations.
    Tilburt J; Ford JG; Howerton MW; Gary TL; Lai GY; Bolen S; Baffi C; Wilson RF; Tanpitukpongse TP; Powe NR; Bass EB; Sugarman J
    Clin Trials; 2007; 4(3):264-9. PubMed ID: 17715253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putting patients on trial.
    Ortolon K
    Tex Med; 2003 Apr; 99(4):37-9. PubMed ID: 12723420
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.
    Colon-Otero G; Smallridge RC; Solberg LA; Keith TD; Woodward TA; Willis FB; Dunn AN
    Cancer; 2008 Feb; 112(3):447-54. PubMed ID: 18085590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why ethnic minority groups are under-represented in clinical trials: a review of the literature.
    Hussain-Gambles M; Atkin K; Leese B
    Health Soc Care Community; 2004 Sep; 12(5):382-8. PubMed ID: 15373816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes, and practices of underserved women in the rural South toward breast cancer prevention and detection.
    Avis-Williams A; Khoury A; Lisovicz N; Graham-Kresge S
    Fam Community Health; 2009; 32(3):238-46. PubMed ID: 19525705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What motivates minorities to participate in research?
    Khaliq W; Gross M; Thyagarajan B; Jones-Webb R
    Minn Med; 2003 Oct; 86(10):39-42. PubMed ID: 14621943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
    McKinney MM; Weiner BJ; Wang V
    Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.